Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study.
Hasan M Al-DorziReem YaqoubReema AlalmaeeGhafran AlmutairiAllulu AlmousaLeen AldawsariPublished in: Journal of nutrition and metabolism (2023)
In COVID-19 patients on NMBA infusion for ARDS, EN was provided early at low doses for most patients, and gastrointestinal intolerance was uncommon in proned and nonproned patients, occurred at a higher rate after discontinuing NMBAs and was associated with worse outcomes. Our study suggests that EN was tolerated and safe in this patient population.